Marshall Financial Group, LLC
Source: SEC Form 13F · as of Mar 2026Marshall Financial Group, LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $17.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$17.8M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 32,442 | $3.9M |
| NVSNovartis AG | 16,986 | $2.6M |
| JNJJOHNSON & JOHNSON | 9,938 | $2.4M |
| AMGNAMGEN INC | 6,023 | $2.1M |
| LLYELI LILLY & Co | 1,801 | $1.7M |
| NVONovo Nordisk A/S | 34,961 | $1.3M |
| UTHRUNITED THERAPEUTICS Corp | 1,813 | $1.1M |
| MEDPMedpace Holdings Inc. | 2,050 | $984K |
| PMPhilip Morris International Inc | 5,852 | $968K |
| ABTABBOTT LABORATORIES | 2,987 | $307K |
| IDXXIDEXX LABORATORIES INC /DE | 477 | $268K |
| ABBVAbbVie Inc. | 1,058 | $230K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.